Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial

The least toxic time (LTT) of irinotecan varied by up to 8 hours according to sex and genetic background in mice. The translational relevance was investigated within a randomized trial dataset, where no LTT stood out significantly in the whole population. 130 male and 63 female eligible patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Innominato, Pasquale F., Ballesta, Annabelle, Huang, Qi, Focan, Christian, Chollet, Philippe, Karaboué, Abdoulaye, Giacchetti, Sylvie, Bouchahda, Mohamed, Adam, René, Garufi, Carlo, Lévi, Francis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300418/
https://www.ncbi.nlm.nih.gov/pubmed/32319740
http://dx.doi.org/10.1002/cam4.3056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300418/
https://www.ncbi.nlm.nih.gov/pubmed/32319740
http://dx.doi.org/10.1002/cam4.3056

Ejemplares similares